SI0840603T1 - Pharmaceutical composition of l-dopa ethyl ester - Google Patents

Pharmaceutical composition of l-dopa ethyl ester

Info

Publication number
SI0840603T1
SI0840603T1 SI9630543T SI9630543T SI0840603T1 SI 0840603 T1 SI0840603 T1 SI 0840603T1 SI 9630543 T SI9630543 T SI 9630543T SI 9630543 T SI9630543 T SI 9630543T SI 0840603 T1 SI0840603 T1 SI 0840603T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical composition
ethyl ester
dopa ethyl
dopa
ester
Prior art date
Application number
SI9630543T
Other languages
Slovenian (sl)
Inventor
Sasson Cohen
Yoram Sela
Ruth Levy
Nava Shterman
Eldad Melamed
Daphne Atlas
Original Assignee
Teva Pharmaceutical Industries, Ltd.
Yissum Research Development Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries, Ltd., Yissum Research Development Company filed Critical Teva Pharmaceutical Industries, Ltd.
Priority claimed from EP96923037A external-priority patent/EP0840603B1/en
Publication of SI0840603T1 publication Critical patent/SI0840603T1/en

Links

SI9630543T 1995-07-21 1996-07-18 Pharmaceutical composition of l-dopa ethyl ester SI0840603T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US136895P 1995-07-21 1995-07-21
EP96923037A EP0840603B1 (en) 1995-07-21 1996-07-18 Pharmaceutical composition of l-dopa ethyl ester
PCT/IL1996/000058 WO1997003662A1 (en) 1995-07-21 1996-07-18 Pharmaceutical composition of l-dopa ethyl ester

Publications (1)

Publication Number Publication Date
SI0840603T1 true SI0840603T1 (en) 2003-02-28

Family

ID=26144805

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9630543T SI0840603T1 (en) 1995-07-21 1996-07-18 Pharmaceutical composition of l-dopa ethyl ester

Country Status (1)

Country Link
SI (1) SI0840603T1 (en)

Similar Documents

Publication Publication Date Title
HUP9601698A3 (en) Pharmaceutical composition of adiabetical activity
IL118637A (en) Oral pharmaceutical compositions of s(+)-ibuprofen
NZ298712A (en) Fatty acid acyl group conjugates as therapeutic compounds
AU4380896A (en) Pharmaceutical composition containing fenofibrate and polyglycolized glycerides
IL118636A (en) Oral pharmaceutical compositions of S(+)-etodolac
GB9519667D0 (en) Pharmaceutical composition
ZA962214B (en) Pharmaceutical composition
HUP0001534A3 (en) Phospholipid derivatives of phosphono-carboxylic acids and pharmaceutical compositions containing them
ZA963397B (en) Esters and pharmaceutical compositions
ZA96525B (en) Novel pharmaceutical compositions
NZ307370A (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
GB9525194D0 (en) Pharmaceutical composition
ZA961051B (en) Pharmaceutical composition
ZA96526B (en) Novel pharmaceutical formulation
SI0840603T1 (en) Pharmaceutical composition of l-dopa ethyl ester
PL323148A1 (en) Esters of crabapenemes
IL122872A0 (en) Quinoxaline-and quinoxalinylalkane-phosphonic acids their preparation and pharmaceutical compositions containing them
IL124321A0 (en) Esters of 3-hydroxy-piperidinemethanol derivatives their preparation and pharmaceutical compositions containing them
PL323141A1 (en) Esters of crabapenemes
HUP9602822A2 (en) Pharmaceutical composition
IL114388A0 (en) Manufacture of pharmaceutical compositions comprising certain arylalkyl-amides
GB9501619D0 (en) Preparation of esters
GB9500685D0 (en) Preparation of esters
ZA964267B (en) Preparation of alkylthiopropionic pentarythritol esters
HUP9602732A2 (en) Pharmaceutical composition comprising lanperisone